nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—HTR2C—Sorafenib—thyroid cancer	0.146	0.424	CbGbCtD
Fluphenazine—CYP1A2—Sorafenib—thyroid cancer	0.053	0.154	CbGbCtD
Fluphenazine—ABCB1—Sorafenib—thyroid cancer	0.0464	0.135	CbGbCtD
Fluphenazine—CYP2D6—Sorafenib—thyroid cancer	0.0437	0.127	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—thyroid cancer	0.0281	0.0819	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—thyroid cancer	0.0265	0.0772	CbGbCtD
Fluphenazine—Corneal opacity—Vandetanib—thyroid cancer	0.0227	0.0924	CcSEcCtD
Fluphenazine—Brain oedema—Vandetanib—thyroid cancer	0.0207	0.0844	CcSEcCtD
Fluphenazine—Glaucoma—Vandetanib—thyroid cancer	0.00786	0.032	CcSEcCtD
Fluphenazine—Faecaloma—Epirubicin—thyroid cancer	0.00516	0.021	CcSEcCtD
Fluphenazine—Faecalith—Epirubicin—thyroid cancer	0.00516	0.021	CcSEcCtD
Fluphenazine—Faecaloma—Doxorubicin—thyroid cancer	0.00477	0.0195	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—thyroid cancer	0.00477	0.0195	CcSEcCtD
Fluphenazine—Pigmentation disorder—Epirubicin—thyroid cancer	0.00442	0.018	CcSEcCtD
Fluphenazine—Lethargy—Vandetanib—thyroid cancer	0.00438	0.0179	CcSEcCtD
Fluphenazine—Pigmentation disorder—Doxorubicin—thyroid cancer	0.00409	0.0167	CcSEcCtD
Fluphenazine—Cardiac arrest—Vandetanib—thyroid cancer	0.00408	0.0166	CcSEcCtD
Fluphenazine—Dysphagia—Vandetanib—thyroid cancer	0.00371	0.0151	CcSEcCtD
Fluphenazine—Gynaecomastia—Sorafenib—thyroid cancer	0.00357	0.0146	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00345	0.0141	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00339	0.0138	CcSEcCtD
Fluphenazine—Pneumonia—Vandetanib—thyroid cancer	0.00333	0.0136	CcSEcCtD
Fluphenazine—Eczema—Sorafenib—thyroid cancer	0.00322	0.0131	CcSEcCtD
Fluphenazine—Renal failure acute—Sorafenib—thyroid cancer	0.00314	0.0128	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00307	0.0125	CcSEcCtD
Fluphenazine—CALM2—neck—thyroid cancer	0.00276	0.0524	CbGeAlD
Fluphenazine—CALM1—neck—thyroid cancer	0.00275	0.0522	CbGeAlD
Fluphenazine—CALM3—saliva-secreting gland—thyroid cancer	0.00274	0.0521	CbGeAlD
Fluphenazine—DRD3—head—thyroid cancer	0.00253	0.0481	CbGeAlD
Fluphenazine—Dysphagia—Sorafenib—thyroid cancer	0.0025	0.0102	CcSEcCtD
Fluphenazine—Muscle spasms—Vandetanib—thyroid cancer	0.00249	0.0101	CcSEcCtD
Fluphenazine—Vision blurred—Vandetanib—thyroid cancer	0.00244	0.00994	CcSEcCtD
Fluphenazine—HTR6—head—thyroid cancer	0.00244	0.0463	CbGeAlD
Fluphenazine—Pneumonia—Sorafenib—thyroid cancer	0.00225	0.00916	CcSEcCtD
Fluphenazine—Hypertension—Vandetanib—thyroid cancer	0.00223	0.0091	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—thyroid cancer	0.00216	0.00882	CcSEcCtD
Fluphenazine—Dry mouth—Vandetanib—thyroid cancer	0.00215	0.00878	CcSEcCtD
Fluphenazine—CALM2—saliva-secreting gland—thyroid cancer	0.00215	0.0409	CbGeAlD
Fluphenazine—CALM1—saliva-secreting gland—thyroid cancer	0.00214	0.0407	CbGeAlD
Fluphenazine—CALM3—trachea—thyroid cancer	0.00211	0.0402	CbGeAlD
Fluphenazine—Skin disorder—Vandetanib—thyroid cancer	0.00205	0.00836	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—thyroid cancer	0.002	0.00816	CcSEcCtD
Fluphenazine—Dermatitis atopic—Epirubicin—thyroid cancer	0.00199	0.00812	CcSEcCtD
Fluphenazine—Dyspnoea—Vandetanib—thyroid cancer	0.00188	0.00767	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00184	0.00752	CcSEcCtD
Fluphenazine—Decreased appetite—Vandetanib—thyroid cancer	0.00183	0.00748	CcSEcCtD
Fluphenazine—DRD1—head—thyroid cancer	0.00181	0.0345	CbGeAlD
Fluphenazine—Constipation—Vandetanib—thyroid cancer	0.0018	0.00736	CcSEcCtD
Fluphenazine—Blood disorder—Epirubicin—thyroid cancer	0.00177	0.0072	CcSEcCtD
Fluphenazine—Liver injury—Epirubicin—thyroid cancer	0.00175	0.00715	CcSEcCtD
Fluphenazine—Erythema—Sorafenib—thyroid cancer	0.00174	0.00711	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00168	0.00684	CcSEcCtD
Fluphenazine—Muscle spasms—Sorafenib—thyroid cancer	0.00168	0.00684	CcSEcCtD
Fluphenazine—HTR2A—neck—thyroid cancer	0.00167	0.0318	CbGeAlD
Fluphenazine—CALM3—thyroid gland—thyroid cancer	0.00167	0.0318	CbGeAlD
Fluphenazine—Body temperature increased—Vandetanib—thyroid cancer	0.00167	0.0068	CcSEcCtD
Fluphenazine—CALM2—trachea—thyroid cancer	0.00166	0.0316	CbGeAlD
Fluphenazine—CALM1—trachea—thyroid cancer	0.00165	0.0314	CbGeAlD
Fluphenazine—Blood disorder—Doxorubicin—thyroid cancer	0.00163	0.00666	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—thyroid cancer	0.00162	0.00661	CcSEcCtD
Fluphenazine—Angioedema—Sorafenib—thyroid cancer	0.00159	0.0065	CcSEcCtD
Fluphenazine—Dyskinesia—Epirubicin—thyroid cancer	0.00157	0.0064	CcSEcCtD
Fluphenazine—Leukopenia—Sorafenib—thyroid cancer	0.00156	0.00637	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00155	0.00633	CcSEcCtD
Fluphenazine—Hypertension—Sorafenib—thyroid cancer	0.00151	0.00614	CcSEcCtD
Fluphenazine—Pruritus—Vandetanib—thyroid cancer	0.00149	0.00609	CcSEcCtD
Fluphenazine—Hepatocellular injury—Epirubicin—thyroid cancer	0.00147	0.00601	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—thyroid cancer	0.00146	0.00594	CcSEcCtD
Fluphenazine—Dry mouth—Sorafenib—thyroid cancer	0.00145	0.00592	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—thyroid cancer	0.00145	0.00592	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00143	0.00584	CcSEcCtD
Fluphenazine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00142	0.00581	CcSEcCtD
Fluphenazine—HTR2C—head—thyroid cancer	0.00141	0.0268	CbGeAlD
Fluphenazine—Skin disorder—Sorafenib—thyroid cancer	0.00138	0.00564	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00136	0.00556	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—thyroid cancer	0.00135	0.0055	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00133	0.0054	CcSEcCtD
Fluphenazine—Headache—Vandetanib—thyroid cancer	0.00132	0.00539	CcSEcCtD
Fluphenazine—CALM2—thyroid gland—thyroid cancer	0.00131	0.025	CbGeAlD
Fluphenazine—CALM1—thyroid gland—thyroid cancer	0.00131	0.0248	CbGeAlD
Fluphenazine—Dyspnoea—Sorafenib—thyroid cancer	0.00127	0.00518	CcSEcCtD
Fluphenazine—Nausea—Vandetanib—thyroid cancer	0.00125	0.00511	CcSEcCtD
Fluphenazine—Decreased appetite—Sorafenib—thyroid cancer	0.00124	0.00505	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—thyroid cancer	0.00122	0.00497	CcSEcCtD
Fluphenazine—Constipation—Sorafenib—thyroid cancer	0.00122	0.00496	CcSEcCtD
Fluphenazine—HRH1—trachea—thyroid cancer	0.00121	0.0229	CbGeAlD
Fluphenazine—Eczema—Epirubicin—thyroid cancer	0.00119	0.00486	CcSEcCtD
Fluphenazine—HTR1A—head—thyroid cancer	0.00119	0.0225	CbGeAlD
Fluphenazine—ADRA2A—trachea—thyroid cancer	0.00118	0.0225	CbGeAlD
Fluphenazine—CALM2—head—thyroid cancer	0.00116	0.0221	CbGeAlD
Fluphenazine—CALM1—head—thyroid cancer	0.00116	0.022	CbGeAlD
Fluphenazine—Renal failure acute—Epirubicin—thyroid cancer	0.00116	0.00473	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00113	0.00463	CcSEcCtD
Fluphenazine—Urticaria—Sorafenib—thyroid cancer	0.00113	0.00461	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—thyroid cancer	0.00113	0.0046	CcSEcCtD
Fluphenazine—Body temperature increased—Sorafenib—thyroid cancer	0.00113	0.00459	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00111	0.00451	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—thyroid cancer	0.0011	0.00449	CcSEcCtD
Fluphenazine—Lethargy—Epirubicin—thyroid cancer	0.00109	0.00445	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—thyroid cancer	0.00107	0.00437	CcSEcCtD
Fluphenazine—DRD2—head—thyroid cancer	0.00107	0.0204	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00105	0.00428	CcSEcCtD
Fluphenazine—Hypersensitivity—Sorafenib—thyroid cancer	0.00105	0.00428	CcSEcCtD
Fluphenazine—CALM3—lymph node—thyroid cancer	0.00104	0.0197	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00102	0.00417	CcSEcCtD
Fluphenazine—CYP1A2—thyroid gland—thyroid cancer	0.00102	0.0194	CbGeAlD
Fluphenazine—Cardiac arrest—Epirubicin—thyroid cancer	0.00102	0.00415	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—thyroid cancer	0.00101	0.00412	CcSEcCtD
Fluphenazine—Pruritus—Sorafenib—thyroid cancer	0.00101	0.00411	CcSEcCtD
Fluphenazine—HTR2A—trachea—thyroid cancer	0.00101	0.0191	CbGeAlD
Fluphenazine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000942	0.00384	CcSEcCtD
Fluphenazine—ADRA2A—thyroid gland—thyroid cancer	0.000936	0.0178	CbGeAlD
Fluphenazine—Dysphagia—Epirubicin—thyroid cancer	0.000925	0.00377	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—thyroid cancer	0.000925	0.00377	CcSEcCtD
Fluphenazine—CYP2E1—thyroid gland—thyroid cancer	0.000916	0.0174	CbGeAlD
Fluphenazine—Eosinophilia—Epirubicin—thyroid cancer	0.000916	0.00374	CcSEcCtD
Fluphenazine—Headache—Sorafenib—thyroid cancer	0.000892	0.00364	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—thyroid cancer	0.000879	0.00358	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00086	0.00351	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—thyroid cancer	0.000856	0.00349	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—thyroid cancer	0.000856	0.00349	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—thyroid cancer	0.000848	0.00346	CcSEcCtD
Fluphenazine—HRH1—head—thyroid cancer	0.000846	0.0161	CbGeAlD
Fluphenazine—Nausea—Sorafenib—thyroid cancer	0.000846	0.00345	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000844	0.00344	CcSEcCtD
Fluphenazine—ADRA2A—head—thyroid cancer	0.000831	0.0158	CbGeAlD
Fluphenazine—Pneumonia—Epirubicin—thyroid cancer	0.00083	0.00338	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—thyroid cancer	0.000825	0.00336	CcSEcCtD
Fluphenazine—CALM2—lymph node—thyroid cancer	0.000816	0.0155	CbGeAlD
Fluphenazine—Pancytopenia—Doxorubicin—thyroid cancer	0.000813	0.00332	CcSEcCtD
Fluphenazine—CYP2E1—head—thyroid cancer	0.000813	0.0154	CbGeAlD
Fluphenazine—CALM1—lymph node—thyroid cancer	0.000812	0.0154	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000796	0.00324	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000781	0.00319	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—thyroid cancer	0.00077	0.00314	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—thyroid cancer	0.000768	0.00313	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—thyroid cancer	0.000763	0.00311	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—thyroid cancer	0.00073	0.00297	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000712	0.0029	CcSEcCtD
Fluphenazine—HTR2A—head—thyroid cancer	0.000706	0.0134	CbGeAlD
Fluphenazine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000675	0.00275	CcSEcCtD
Fluphenazine—ABCB1—trachea—thyroid cancer	0.00066	0.0125	CbGeAlD
Fluphenazine—Erythema—Epirubicin—thyroid cancer	0.000645	0.00263	CcSEcCtD
Fluphenazine—CYP2D6—head—thyroid cancer	0.000644	0.0122	CbGeAlD
Fluphenazine—Muscle spasms—Epirubicin—thyroid cancer	0.00062	0.00253	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—thyroid cancer	0.000608	0.00248	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—thyroid cancer	0.000596	0.00243	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—thyroid cancer	0.000592	0.00242	CcSEcCtD
Fluphenazine—HRH1—lymph node—thyroid cancer	0.000592	0.0113	CbGeAlD
Fluphenazine—ADRA2A—lymph node—thyroid cancer	0.000582	0.0111	CbGeAlD
Fluphenazine—Leukopenia—Epirubicin—thyroid cancer	0.000577	0.00235	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—thyroid cancer	0.000573	0.00234	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—thyroid cancer	0.000562	0.00229	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—thyroid cancer	0.000557	0.00227	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—thyroid cancer	0.000548	0.00224	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—thyroid cancer	0.000537	0.00219	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—thyroid cancer	0.000534	0.00218	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000526	0.00215	CcSEcCtD
Fluphenazine—ABCB1—thyroid gland—thyroid cancer	0.000522	0.00992	CbGeAlD
Fluphenazine—Hypertension—Doxorubicin—thyroid cancer	0.000515	0.0021	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—thyroid cancer	0.000513	0.00209	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—thyroid cancer	0.000511	0.00208	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—thyroid cancer	0.000497	0.00203	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—thyroid cancer	0.000492	0.002	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000487	0.00199	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—thyroid cancer	0.000475	0.00194	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—thyroid cancer	0.000473	0.00193	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—thyroid cancer	0.000469	0.00191	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—thyroid cancer	0.000468	0.00191	CcSEcCtD
Fluphenazine—ABCB1—head—thyroid cancer	0.000463	0.0088	CbGeAlD
Fluphenazine—Decreased appetite—Epirubicin—thyroid cancer	0.000457	0.00187	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—thyroid cancer	0.000455	0.00186	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—thyroid cancer	0.00045	0.00183	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—thyroid cancer	0.000434	0.00177	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—thyroid cancer	0.000433	0.00176	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—thyroid cancer	0.000423	0.00173	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—thyroid cancer	0.000418	0.0017	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—thyroid cancer	0.000416	0.0017	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—thyroid cancer	0.000416	0.0017	CcSEcCtD
Fluphenazine—Hypersensitivity—Epirubicin—thyroid cancer	0.000388	0.00158	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—thyroid cancer	0.000387	0.00158	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—thyroid cancer	0.000385	0.00157	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—thyroid cancer	0.000372	0.00152	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000359	0.00146	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—thyroid cancer	0.000344	0.0014	CcSEcCtD
Fluphenazine—Headache—Epirubicin—thyroid cancer	0.00033	0.00134	CcSEcCtD
Fluphenazine—ABCB1—lymph node—thyroid cancer	0.000324	0.00616	CbGeAlD
Fluphenazine—Nausea—Epirubicin—thyroid cancer	0.000313	0.00127	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—thyroid cancer	0.000305	0.00124	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—thyroid cancer	0.000289	0.00118	CcSEcCtD
Fluphenazine—CALM3—Hemostasis—TP53—thyroid cancer	3.22e-05	8.97e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRG1—thyroid cancer	3.19e-05	8.89e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	3.18e-05	8.86e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	3.16e-05	8.82e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—KRAS—thyroid cancer	3.15e-05	8.79e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—KRAS—thyroid cancer	3.15e-05	8.79e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—RXRA—thyroid cancer	3.15e-05	8.78e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	3.15e-05	8.77e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	3.14e-05	8.75e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—BRAF—thyroid cancer	3.13e-05	8.73e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—BRAF—thyroid cancer	3.13e-05	8.73e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—KRAS—thyroid cancer	3.13e-05	8.72e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CCND1—thyroid cancer	3.12e-05	8.69e-05	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TP53—thyroid cancer	3.11e-05	8.67e-05	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TP53—thyroid cancer	3.11e-05	8.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRG1—thyroid cancer	3.09e-05	8.6e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRG1—thyroid cancer	3.09e-05	8.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—HRAS—thyroid cancer	3.08e-05	8.58e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PPARG—thyroid cancer	3.05e-05	8.51e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—KRAS—thyroid cancer	3.03e-05	8.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—KRAS—thyroid cancer	3.03e-05	8.44e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—PTEN—thyroid cancer	3.01e-05	8.39e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	3e-05	8.37e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—AKT1—thyroid cancer	2.98e-05	8.3e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.98e-05	8.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—HRAS—thyroid cancer	2.98e-05	8.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—HRAS—thyroid cancer	2.98e-05	8.3e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	2.96e-05	8.24e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—AKT1—thyroid cancer	2.94e-05	8.19e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	2.91e-05	8.1e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	2.9e-05	8.09e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	2.9e-05	8.07e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	2.88e-05	8.03e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TERT—thyroid cancer	2.86e-05	7.98e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—HRAS—thyroid cancer	2.86e-05	7.98e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—HRAS—thyroid cancer	2.83e-05	7.87e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PPARG—thyroid cancer	2.8e-05	7.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PPARG—thyroid cancer	2.79e-05	7.76e-05	CbGpPWpGaD
Fluphenazine—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	2.78e-05	7.76e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—BRAF—thyroid cancer	2.78e-05	7.74e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TERT—thyroid cancer	2.77e-05	7.72e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TERT—thyroid cancer	2.77e-05	7.72e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—HRAS—thyroid cancer	2.77e-05	7.72e-05	CbGpPWpGaD
Fluphenazine—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	2.75e-05	7.66e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HIF1A—thyroid cancer	2.74e-05	7.64e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	2.73e-05	7.62e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—BRAF—thyroid cancer	2.73e-05	7.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—AKT1—thyroid cancer	2.72e-05	7.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PPARG—thyroid cancer	2.69e-05	7.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PPARG—thyroid cancer	2.69e-05	7.51e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NRAS—thyroid cancer	2.69e-05	7.49e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CCND1—thyroid cancer	2.68e-05	7.48e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—HRAS—thyroid cancer	2.68e-05	7.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—HRAS—thyroid cancer	2.68e-05	7.47e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—RXRA—thyroid cancer	2.67e-05	7.44e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—HRAS—thyroid cancer	2.66e-05	7.41e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HIF1A—thyroid cancer	2.65e-05	7.39e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HIF1A—thyroid cancer	2.65e-05	7.39e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CCND1—thyroid cancer	2.65e-05	7.38e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	2.65e-05	7.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—AKT1—thyroid cancer	2.63e-05	7.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—AKT1—thyroid cancer	2.63e-05	7.32e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTGS2—thyroid cancer	2.62e-05	7.29e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.6e-05	7.24e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PTEN—thyroid cancer	2.59e-05	7.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—HRAS—thyroid cancer	2.57e-05	7.17e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—HRAS—thyroid cancer	2.57e-05	7.17e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PTEN—thyroid cancer	2.56e-05	7.13e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	2.54e-05	7.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTGS2—thyroid cancer	2.53e-05	7.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTGS2—thyroid cancer	2.53e-05	7.06e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—AKT1—thyroid cancer	2.53e-05	7.05e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	2.5e-05	6.97e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	2.5e-05	6.96e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—AKT1—thyroid cancer	2.49e-05	6.95e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	2.49e-05	6.93e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PTEN—thyroid cancer	2.47e-05	6.89e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	2.46e-05	6.86e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	2.45e-05	6.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—AKT1—thyroid cancer	2.45e-05	6.82e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—NRAS—thyroid cancer	2.41e-05	6.73e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTGS2—thyroid cancer	2.4e-05	6.69e-05	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	2.39e-05	6.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PTEN—thyroid cancer	2.39e-05	6.66e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PTEN—thyroid cancer	2.39e-05	6.66e-05	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	2.38e-05	6.64e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—AKT1—thyroid cancer	2.37e-05	6.59e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—AKT1—thyroid cancer	2.37e-05	6.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—AKT1—thyroid cancer	2.35e-05	6.55e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—NRAS—thyroid cancer	2.33e-05	6.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—NRAS—thyroid cancer	2.33e-05	6.51e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NRAS—thyroid cancer	2.31e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KRAS—thyroid cancer	2.31e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	2.31e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	2.3e-05	6.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTEN—thyroid cancer	2.28e-05	6.36e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NRAS—thyroid cancer	2.28e-05	6.36e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	2.28e-05	6.35e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—AKT1—thyroid cancer	2.27e-05	6.33e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—AKT1—thyroid cancer	2.27e-05	6.33e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—BRAF—thyroid cancer	2.27e-05	6.32e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	2.23e-05	6.21e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	2.22e-05	6.18e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTEN—thyroid cancer	2.21e-05	6.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTEN—thyroid cancer	2.21e-05	6.15e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTGS2—thyroid cancer	2.21e-05	6.15e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—NRAS—thyroid cancer	2.21e-05	6.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—BRAF—thyroid cancer	2.19e-05	6.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—BRAF—thyroid cancer	2.19e-05	6.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTGS2—thyroid cancer	2.19e-05	6.11e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	2.17e-05	6.06e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	2.16e-05	6.03e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	2.16e-05	6.03e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NRAS—thyroid cancer	2.13e-05	5.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NRAS—thyroid cancer	2.13e-05	5.95e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	2.13e-05	5.93e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	2.12e-05	5.92e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTGS2—thyroid cancer	2.12e-05	5.91e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—thyroid cancer	2.12e-05	5.91e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PPARG—thyroid cancer	2.11e-05	5.88e-05	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	2.1e-05	5.86e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTEN—thyroid cancer	2.09e-05	5.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—KRAS—thyroid cancer	2.08e-05	5.79e-05	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	2.07e-05	5.76e-05	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	2.06e-05	5.75e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—thyroid cancer	2.05e-05	5.73e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NRAS—thyroid cancer	2.04e-05	5.67e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCND1—thyroid cancer	2.03e-05	5.65e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—KRAS—thyroid cancer	2.01e-05	5.6e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—KRAS—thyroid cancer	2.01e-05	5.6e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.99e-05	5.56e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.99e-05	5.55e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KRAS—thyroid cancer	1.99e-05	5.55e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.99e-05	5.55e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.99e-05	5.54e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.98e-05	5.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NRAS—thyroid cancer	1.97e-05	5.49e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NRAS—thyroid cancer	1.97e-05	5.49e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—HRAS—thyroid cancer	1.96e-05	5.48e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KRAS—thyroid cancer	1.96e-05	5.47e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.96e-05	5.45e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.94e-05	5.39e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.93e-05	5.37e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTEN—thyroid cancer	1.92e-05	5.36e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.92e-05	5.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTEN—thyroid cancer	1.91e-05	5.33e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.91e-05	5.32e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—thyroid cancer	1.9e-05	5.29e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.88e-05	5.24e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.88e-05	5.23e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.87e-05	5.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTEN—thyroid cancer	1.85e-05	5.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTEN—thyroid cancer	1.85e-05	5.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—thyroid cancer	1.84e-05	5.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—thyroid cancer	1.84e-05	5.12e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.81e-05	5.06e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—thyroid cancer	1.77e-05	4.93e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—thyroid cancer	1.77e-05	4.92e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—thyroid cancer	1.75e-05	4.88e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.75e-05	4.88e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.75e-05	4.87e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—thyroid cancer	1.75e-05	4.86e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—thyroid cancer	1.74e-05	4.84e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.72e-05	4.79e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—thyroid cancer	1.71e-05	4.78e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.71e-05	4.77e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.71e-05	4.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—thyroid cancer	1.71e-05	4.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—thyroid cancer	1.71e-05	4.76e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.7e-05	4.74e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—thyroid cancer	1.7e-05	4.72e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—thyroid cancer	1.7e-05	4.72e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—thyroid cancer	1.69e-05	4.71e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARG—thyroid cancer	1.69e-05	4.7e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—thyroid cancer	1.67e-05	4.65e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—thyroid cancer	1.66e-05	4.63e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—thyroid cancer	1.66e-05	4.61e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—thyroid cancer	1.61e-05	4.5e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—thyroid cancer	1.6e-05	4.46e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—thyroid cancer	1.6e-05	4.46e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—thyroid cancer	1.6e-05	4.45e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.57e-05	4.36e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	1.56e-05	4.36e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—thyroid cancer	1.56e-05	4.35e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—thyroid cancer	1.56e-05	4.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—thyroid cancer	1.56e-05	4.35e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—thyroid cancer	1.55e-05	4.31e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—thyroid cancer	1.55e-05	4.31e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—thyroid cancer	1.52e-05	4.24e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—thyroid cancer	1.51e-05	4.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—thyroid cancer	1.51e-05	4.2e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—thyroid cancer	1.51e-05	4.2e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—thyroid cancer	1.5e-05	4.19e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—thyroid cancer	1.49e-05	4.16e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—thyroid cancer	1.49e-05	4.15e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	1.48e-05	4.12e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—thyroid cancer	1.48e-05	4.11e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—thyroid cancer	1.47e-05	4.11e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	1.45e-05	4.05e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—thyroid cancer	1.45e-05	4.04e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	1.45e-05	4.03e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—thyroid cancer	1.44e-05	4.02e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—thyroid cancer	1.44e-05	4.02e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—thyroid cancer	1.43e-05	3.97e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—thyroid cancer	1.42e-05	3.97e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—thyroid cancer	1.38e-05	3.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—thyroid cancer	1.38e-05	3.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—thyroid cancer	1.38e-05	3.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—thyroid cancer	1.38e-05	3.84e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—thyroid cancer	1.36e-05	3.8e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	1.34e-05	3.75e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—thyroid cancer	1.34e-05	3.72e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.33e-05	3.7e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—thyroid cancer	1.32e-05	3.67e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—thyroid cancer	1.31e-05	3.66e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—thyroid cancer	1.31e-05	3.65e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	1.28e-05	3.58e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	1.28e-05	3.56e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—thyroid cancer	1.28e-05	3.56e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—thyroid cancer	1.27e-05	3.55e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—thyroid cancer	1.27e-05	3.55e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	1.26e-05	3.5e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—thyroid cancer	1.25e-05	3.49e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—thyroid cancer	1.23e-05	3.42e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—thyroid cancer	1.21e-05	3.36e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	1.2e-05	3.33e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—thyroid cancer	1.19e-05	3.31e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—thyroid cancer	1.19e-05	3.31e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—thyroid cancer	1.16e-05	3.22e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	1.14e-05	3.19e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—thyroid cancer	1.13e-05	3.14e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	1.11e-05	3.09e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—thyroid cancer	1.11e-05	3.09e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—thyroid cancer	1.11e-05	3.09e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—thyroid cancer	1.1e-05	3.07e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—thyroid cancer	1.09e-05	3.04e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—thyroid cancer	1.07e-05	2.97e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—thyroid cancer	1.07e-05	2.97e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—thyroid cancer	1.06e-05	2.94e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—thyroid cancer	1.06e-05	2.94e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—thyroid cancer	1.04e-05	2.91e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	1.01e-05	2.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—thyroid cancer	1.01e-05	2.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—thyroid cancer	1.01e-05	2.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—thyroid cancer	9.21e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—thyroid cancer	8.91e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—thyroid cancer	8.91e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—thyroid cancer	8.35e-06	2.33e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—thyroid cancer	7.87e-06	2.19e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—thyroid cancer	6.66e-06	1.86e-05	CbGpPWpGaD
